Welcome to LookChem.com Sign In|Join Free
  • or
2-{3-[2-(2,4-dimethylphenyl)-5-methyloxazol-4-ylmethoxy]cyclohexyloxymethyl}-6-methylbenzoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

501362-53-4

Post Buying Request

501362-53-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

501362-53-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 501362-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,3,6 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 501362-53:
(8*5)+(7*0)+(6*1)+(5*3)+(4*6)+(3*2)+(2*5)+(1*3)=104
104 % 10 = 4
So 501362-53-4 is a valid CAS Registry Number.

501362-53-4Downstream Products

501362-53-4Relevant academic research and scientific papers

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

-

, (2008/06/13)

Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts an

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals

-

Page 26, (2010/02/07)

Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.

Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals

-

, (2008/06/13)

Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts an

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 501362-53-4